Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jan 20;12:1756284818820438. doi: 10.1177/1756284818820438

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 4. — Comparative effectiveness of the 14 different interventions: surface under the cumulative ranking curves (SUCRA) for improving overall symptoms in irritable bowel syndrome patients.

The x-axis represents the possible rank of each treatment (from the first best rank to the worst according to the improvement on overall IBS symptoms.) The y-axis indicates the cumulative probability for each treatment to be the best treatment, the second-best treatment, the third best treatment, and so on.

Acu, needle acupuncture; A&G, needle acupuncture plus Geshanxiaoyao formula; A&M, needle acupuncture plus moxibustion; Bif, Bifidobacterium; Cat, catgut embedding; C&T, catgut embedding plus trimebutine maleate; Elect, Electroacupuncture; Ges, Geshanxiaoyao formula; Lop, loperamide; Mox, moxibustion; Periorbit, periorbital acupuncture; Pin, pinaverium bromide; Ton, Tongxieyaofang; Tri, trimebutine maleate.